# Study on Quality of Life in Advanced Cancer Patients With Opioid-induced Constipation Treated With Naloxegol

> **NCT04294550** · — · COMPLETED · sponsor: **Fondazione ANT Italia ONLUS** · enrollment: 250 (actual)

## Conditions studied

- Opioid Use
- Constipation Drug Induced
- Cancer

## Interventions

- **OTHER:** Naloxegol

## Key facts

- **NCT ID:** NCT04294550
- **Lead sponsor:** Fondazione ANT Italia ONLUS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2021-03-31
- **Target enrollment:** 250 (ACTUAL)
- **Last updated:** 2022-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04294550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04294550, "Study on Quality of Life in Advanced Cancer Patients With Opioid-induced Constipation Treated With Naloxegol". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04294550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
